Hypoxia stimulates proliferation and interleukin-1β production in human vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 4 46-4, 1999, Pages

  Cooper, Angela L ^a   Beasley, Debbie ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Interleukin 1 receptor antagonist; Oxygen tension; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGENIC AGENT; OXYGEN; TUMOR NECROSIS FACTOR ALPHA;

AORTA; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HYPOXIA; OXYGEN TENSION; PRIORITY JOURNAL; PULMONARY ARTERY; REOXYGENATION; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE;

EID: 0032711658     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.4.h1326     Document Type: Article

References (63)

1. Astrup, P., K. Kjeldsen, and J. Wanstrup. Effects of carbon monoxide exposure on the arterial walls. Ann. NY Acad. Sci. 174: 294-300, 1974.
2. Barker, S. G. E., A. Talbert, S. Cottam, P. A. Baskerville, and J. F. Martin. Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. Arterioscler. Thromb. 13: 70-77, 1993.
3. Barker, S. G. E., L. D. Tilling, G. C. Miller, J. E. Beesley, G. Fleetwood, G. T. Stavri, P. A. Baskerville, and J. F. Martin. The adventitia and atherogenesis: removal initiates intimal proliferation in the rabbit which regresses on generation of a "neoadventitia." Atherosclerosis 105: 131-144, 1994.
4. Beaslesy, D., and A. Cooper. Constitutive expression of interleukin-1α precursor promotes human vascular smooth muscle cell proliferation. Am. J. Physiol. 276 (Heart Circ. Physiol. 45): H901-H912, 1999.
5. Beasley, D., and M. McGuiggin. Interleukin-1 activates soluble guanylate cyclase in human vascular smooth muscle cells via a novel NO-independent pathway. J. Exp. Med. 179: 71-80, 1994.
6. Beasley, D., M. McGuiggin, and C. A. Dinarello. Human vascular smooth muscle cells produce an intracellular form of interleukin-1 receptor antagonist. Am. J. Physiol. 269 (Cell Physiol. 38): C961-C968, 1995.
7. Benitz, W. E., J. D. Coulson, D. S. Lessler, and M. Bernfield. Hypoxia inhibits proliferation of fetal pulmonary arterial smooth muscle cells in vitro. Pediatr. Res. 20: 966-971, 1986.
8. Benzakour, O., C. Kanthou, S. M. Kanse, M. R. Scully, V. V. Kakkar, and D. N. Cooper. Evidence for cultured human vascular smooth muscle cell heterogeneity: isolation of clonal cells and study of their growth characteristics. Thromb. Haemost. 75: 854-858, 1996.
9. Bjornheden, T., and G. Bondjers. Oxygen consumption in aortic tissue from rabbits with diet-induced atherosclerosis. Arteriosclerosis 7: 238-247, 1987.
10. Bourcier, T., M. Dockter, and A. Hassid. Synergistic interaction of interleukin-1β and growth factors in primary cultures of rat aoitic smooth muscle cells. J. Cell. Physiol. 164: 644-657, 1995.
11. Brown, M. S., Y. K. Ho, and J. L. Goldstein. The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J. Biol. Chem. 255: 9344-9352, 1980.
12. Clark, E. T., T. R. Desai, K. L. Hynes, and B. L. Gewertz. Endothelial cell response to hypoxia-reoxygenation is mediated by IL-1. J. Surg. Res. 58: 675-681, 1995.
13. Conlon, P. J., K. H. Grabstein, A. Alpert, K. S. Prickett, T. P. Hopp, and S. Gillis. Localization of human mononuclear cell interleukm 1. J. Immunol. 139: 98-102, 1987.
14. Cornwell, T., E. Arnold, N. Boerth, and T. Lincoln. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 267 (Cell Physiol. 36): C1405-C1413, 1994.
15. Crawford, D. W., and D. H. Blackenhorn. Arterial wall oxygenation, oxyradicals and atherosclerosis. Atherosclerosis 89: 97-108, 1991.
16. Dean, R. T., and I. Wilcox. Possible atherogenic effects of hypoxia during obstructive sleep apnea. Sleep 16: S15-S22, 1993.
17. Dempsey, E. C., M. Ditas, M. G. Frid, Y. Xu, and K. R. Stenmark. Hypoxic growth of bovine pulmonary artery smooth muscle cells. Dependence on synergy, heterogeneity, and injury-induced phenotypic change. Chest 114: 29S-30S, 1998.
18. Dempsey, E. C., I. F. McMurtry, and R. F. O'Brien. Protein kinase C activation allows pulmonary artery smooth muscle cells to proliferate to hypoxia. Am. J. Physiol. 260 (Lung Cell. Mol. Physiol. 4): L136-L145, 1991.
19. Frid, M. G., A. A. Aldashev, E. C. Dempsey, and K. R. Stenmark. Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities. Circ. Res. 81: 940-952, 1997.
20. Frid, M. G., E. C. Dempsey, A. G. Durmowicz, and K. R. Stenmark. Smooth muscle cell heterogeneity in pulmonary and sytemic vessels: importance in vascular disease. Arterioscler. Thromb. Vasc. Biol. 17: 1203-1209, 1997.
21. Frid, M. G., E. P. Moiseeva, and K. R. Stenmark. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ. Res. 75: 669-681, 1994.
22. Fujita, H., K. Shimokado, C. Yurani, S. Takaichi, J. Masada, and J. Agata. Human neonatal and adult vascular smooth muscle cells in culture. Exp. Mol. Pathol. 58: 25-39, 1993.
23. Fukuo, K., T. Inoue, S. Morimoto, T. Nakahashi, O. Yasuda, S. Kitano, R. Sasada, and T. Ogihara. Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. J. Clin. Invest. 95: 669-676, 1995.
24. Ghezzi, P., C. A. Dinarello, M. Bianchi, M. E. Rosandich, J. E. Repine, and C. W. White. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 3: 189-194, 1991.
25. Glukhova, M., A. E. Kabakon, M. G. Frid, O. I. Ornatsky, A. M. Belkin, D. N. Mukhin, A. N. Orekhov, V. E. Koteliansky, and V. N. Smirnov. Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc. Natl. Acad. Sci. USA 85: 9542-9546, 1988.
26. Grassi, J., C. J. Roberge, Y. Frobert, P. Pradelles, and P. E. Poubelle. Determination of IL1α, IL1β, and IL2 in biological media using specific enzyme immunometric assays. Immunol. Rev. 119: 125-145, 1991.
27. Hales, C. A. Pulmonary hypertension: vasoconstriction and vascular remodeling. Semin. Respir. Med. 7: 136-140, 1985.
28. Hannum, C. H., C. F. Wilcox, W. P. Arend, F. G. Joslin, D. J. Dripps, P. L. Heimdal, L. G. Armes, A. Sommer, S. P. Eisenberg, and R. C. Thompson. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343: 336-340, 1990.
29. Hassoun, P. M., P. J. Pasricha, E. Teufel, S. L. Lee, and B. L. Fanburg. Hypoxia stimulates the release by bovine pulmonary artery endothelial cells of an inhibitor of pulmonary artery smooth muscle cell growth. Am. J. Respir. Cell Mol. Biol. 1: 377-384, 1989.
30. Hassoun, P. M., A. L. Shedd, J. J. Lanzillo, V. Thappa, M. J. Landman, and B. L. Fanburg. Inhibition of pulmonary artery smooth muscle cell growth by hypoxanthine, xanthine, and uric acid. Am. J. Respir. Cell Mol. Biol. 6: 617-624, 1992.
31. Ikeda, U., M. Ikeda, T. Oohara, S. Kano, and T. Yaginuma. Mitogenic action of interleukin-1 alpha on vascular smooth muscle cells mediated by PDGF. Atherosclerosis 84: 183-188, 1990.
32. Kaplanski, G., C. Farnarier, S. Kaplanski, R. Porat, L. Shapiro, P. Bongrand, and C. Dinarello. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 84: 1-7, 1994.
33. Kjeldsen, K., P. Astrup, and J. Wanstrup. Reversal of rabbit atheromatosis by hyperoxia (Abstract). J. Atheroscler. Res. 10: 173, 1969.
34. Kjeldsen, K., J. Wanstrup, and P. Astrup. Enhancing influence of arterial hypoxia on the development of atheromatosis in cholesterol-fed rabbits. J. Atheroscler. Res. 8: 835-845, 1968.
35. Koga, S., S. Ogawa, K. Kuwabar, J. Brett, J. A. Leavy, J. Ryan, Y. Koga, J. Plocinski, W. Benjamin, D. K. Burns, and D. Stern. Synthesis and release of interleukin 1 by reoxygenated human mononuclear phagocytes. J. Clin. Invest. 90: 1007-1015, 1992.
36. Ku, G., N. Doherty, J. Wolos, R. Jackson, L. Schmidt, and D. Hendricks. Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis. Am. J. Cardiol. 62: 77B-81B, 1988.
37. Kuehl, K. S., S. P. Bruttig, D. V. Singer, R. Rubio, and R. M. Berne. Growth of aortic vascular smooth muscle cells in lowered oxygen tension. Cell Tissue Res. 216: 591-602, 1981.
38. Kurt-Jones, E. A., D. I. Beller, S. B. Mizel, and E. R. Unanue. Identification of a membrane-associated interleukin-1 in macrophages. Proc. Natl. Acad. Sci. USA 82: 1204-1208, 1985.
39. Libby, P., J. M. Ordovas, L. K. Birinyi, and C. A. Dinarello. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J. Clin. Invest. 78: 1432-1438, 1986.
40. Libby, P., S. J. Warner, and G. B. Friedman. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J. Clin. Invest. 81: 487-498, 1988.
41. Loppnow, H., and P. Libby. Functional significance of human vascular smooth muscle cell-derived interleukin-1 in paracrine and autocrine regulation pathways. Exp. Cell Res. 198: 283-290, 1992.
42. Maier, J. A. M., M. Statuto, and G. Ragnotti. Endogenous interleukin 1 alpha must be transported to the nucleus to exerts its activity in human endothelial cells. Mol. Cell. Biol. 14: 1845-1851, 1994.
43. Martin, J. F., R. F. G. Booth, and S. Moncada. Arterial wall hypoxia following thrombosis of the vasa vasorum is an initial lesion in atherosclerosis. Eur. J. Clin. Invest. 21: 355-359, 1991.
44. Meyrick, B., and L. Reid. The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study. Lab. Invest. 38: 188-199, 1978.
45. Michiels, C., F. D. Leener, T. Arnould, M. Dieu, and J. Remade. Hypoxia stimulates human endothelial cells to release smooth muscle cell mitogens: role of prostaglandins and bFGF. Exp. Cell Res. 213: 43-54, 1994.
46. Mosley, B., S. K. Dower, S. Gillis, and D. Cosman. Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1α and 1β. Proc. Natl. Acad. Sci. USA 84: 4572-4576, 1987.
47. Nakata, Y., and S. Shionoya. Vascular lesions due to obstruction of the vasa vasorum. Nature 212: 1258-1259, 1966.
48. Palmer, H., and P. Libby. Interferon-β: a potential autocrine regulator of human vascular smooth muscle cell growth. Lab. Invest. 66: 715-721, 1992.
49. Poutsiaka, D. D., B. D. Clark, E. Vannier, and C. A. Dinarello. Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated. Blood 78: 1275-1281, 1991.
50. Reid, L. M. The pulmonary circulation: remodeling in growth and disease. Am. Rev. Respir. Dis. 119: 531-546, 1979.
51. Sawada, H., M. Kan, and W. L. McKeehan. Opposite effects of monokines (interleukin-1 and tumor necrosis factor) on proliferation and heparin-binding (fibroblast) growth factor binding to human aortic endothelial and smooth muscle cells. In Vitro Cell. Dev. Biol. 26: 213-216, 1990.
52. Schneiderman, G., and T. K. Goldstick. Carbon monoxide-induced arterial wall hypoxia and atherosclerosis. Atherosclerosis 30: 1-15, 1978.
53. Scott-Burden, T., V. B. Schini, E. Elizondo, D. C. Junquero, and P. M. Vanhoutte. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ. Res. 71: 1088-1100, 1992.
54. Shreeniwas, R., S. Koga, M. Karakurum, D. Pinsky, E. Kaiser, B. J., B. A. Wolistky, C. Norton, J. Plocinski, W. Benjamin, D. K. Burns, A. Goldstein, and D. Stern. Hypoxia-mediated induction of endothelial cell interleukin-1α: an autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J. Clin. Invest. 90: 2333-2339, 1992.
55. Thilo-Korner, D. G. S., U. Marre, N. Savion, F. W. Hehrlein, and R. H. Bodeker. Hyperoxia (145 mmHg pO2) and tissue normoxia (20-40 mmHg pO2) modulate human vascular cell functions. EXS 61: 400-404, 1992.
56. Vender, R. L. Role of endothelial cells in the proliferative response of cultured pulmonary vascular smooth muscle cells to reduced oxygen tension. In Vitro Cell. Dev. Biol. 28A: 403-409, 1992.
57. Vender, R. L., D. R. Clemmons, L. Kwock, and M. Friedman. Reduced oxygen tension induces pulmonary endothelium to release a pulmonary smooth muscle cell mitogen(s). Am. Rev. Respir. Dis. 135: 622-627, 1987.
58. Warner, S. J., and P. Libby. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J. Immunol. 142: 100-109, 1989.
59. Watson, J. M., A. K. Lofquist, C. A. Rinehart, J. C. Olsen, S. S. Makarov, D. G. Kaufman, and J. S. Haskill. The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1β. J. Immunol. 155: 4467-4475, 1995.
60. Wessendorf, J. H. M., S. Garfinkel, X. Zhan, S. Brown, and T. Maciag. Identification of a nuclear localization sequence within the structure of the human interleukin-1α precursor. J. Biol. Chem. 268: 22100-22104, 1993.
61. Whereat, A. F. Oxygen consumption of normal and atherosclerotic intima. Circ. Res. 9: 571-575, 1961.
62. Wohrley, J. D., M. G. Frid, E. P. Moiseeva, E. C. Orton, J. K. Belknap, and K. R. Stenmark. Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J. Clin. Invest. 96: 273-281, 1995.
63. Zola, H., L. Flego, Y. T. Wong, P. J. Macardle, and J. S. Kenney. Direct demonstration of membrane IL-1α on the surface of circulating B lymphocytes and monocytes. J. Immunol. 150: 1755-1762, 1993.